Arena Pharmaceuticals, Inc. Retained Earnings
Arena Pharmaceuticals, Inc. had Retained Earnings of -$2.12 billion as of 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-02-23
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$2.12B.
- 2021-09-30: Retained Earnings (Accumulated Deficit) -$1.97B.
- 2021-06-30: Retained Earnings (Accumulated Deficit) -$1.77B.
- 2021-03-31: Retained Earnings (Accumulated Deficit) -$1.63B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2021-12-31 | -$2.12B 10-K · filed 2022-02-23 |
| 2021-09-30 | -$1.97B 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$1.77B 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$1.63B 10-Q · filed 2021-05-05 |
| 2020-12-31 | -$1.51B 10-K · filed 2022-02-23 |
| 2020-09-30 | -$1.39B 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$1.29B 10-Q · filed 2020-08-05 |
| 2020-03-31 | -$1.20B 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$1.10B 10-K · filed 2021-02-23 |
| 2019-09-30 | -$1.01B 10-Q · filed 2019-11-08 |
| 2019-06-30 | -$941.82M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$880.42M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$1.50B 10-K · filed 2020-02-27 |
| 2018-09-30 | -$1.57B 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$1.53B 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$1.50B 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$1.49B 10-K · filed 2019-02-28 |
| 2017-09-30 | -$1.48B 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$1.44B 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$1.42B 10-Q · filed 2017-05-09 |
| 2016-12-31 | -$1.40B 10-K · filed 2018-03-14 |
| 2016-09-30 | -$1.44B 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$1.42B 10-Q · filed 2016-08-09 |
| 2016-03-31 | -$1.40B 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$1.38B 10-K · filed 2017-03-15 |
| 2015-09-30 | -$1.35B 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$1.32B 10-Q · filed 2015-08-07 |
| 2015-03-31 | -$1.29B 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$1.27B 10-K · filed 2016-02-29 |
| 2014-09-30 | -$1.24B 10-Q · filed 2014-11-06 |
| 2014-06-30 | -$1.23B 10-Q · filed 2014-08-06 |
| 2014-03-31 | -$1.23B 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$1.21B 10-K · filed 2015-03-02 |
| 2013-09-30 | -$1.18B 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$1.17B 10-Q · filed 2013-08-05 |
| 2013-03-31 | -$1.21B 10-Q · filed 2013-05-09 |
| 2012-12-31 | -$1.19B 10-K · filed 2014-03-03 |
| 2012-09-30 | -$1.17B 10-Q · filed 2012-11-09 |
| 2012-06-30 | -$1.15B 10-Q · filed 2012-08-09 |
| 2012-03-31 | -$1.11B 10-Q · filed 2012-05-02 |
| 2011-12-31 | -$1.08B 10-K · filed 2013-03-01 |
| 2011-09-30 | -$1.06B 10-Q · filed 2011-11-09 |
| 2011-06-30 | -$1.03B 10-Q · filed 2011-08-09 |
| 2010-12-31 | -$970.53M 10-K · filed 2012-03-15 |